APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tuberculosis (TB) Diagnostics

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

Selected research

Market Structure

Global Tuberculosis (TB) Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025196 pages

Choose your research edition.

Industry ResearchTuberculosis (TB) Diagnostics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculosis (TB) Diagnostics Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Tuberculosis (TB) Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculosis (TB) Diagnostics Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculosis (TB) Diagnostics Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.

APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.

Read the full market overview

In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.

Report Includes

This report provides an overview of the global Tuberculosis (TB) Diagnostics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tuberculosis (TB) Diagnostics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tuberculosis (TB) Diagnostics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Tuberculosis (TB) Diagnostics market size, projected growth trends, production technologies, key applications, and end-use industries.

Tuberculosis (TB) Diagnostics Segment by Company

Danaher

Roche

Thermo Fisher Scientific

BD

Abbott

Hologic

Qiagen

BioMerieux

Hain Lifescience

Oxford Immunotec

Tuberculosis (TB) Diagnostics Segment by Type

Culture-Based Diagnostics

Sputum Smear Microscopy

Rapid Molecular Diagnostics

Others

Tuberculosis (TB) Diagnostics Segment by Application

Diagnostic Laboratories

Hospitals

Tuberculosis (TB) Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Tuberculosis (TB) Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tuberculosis (TB) Diagnostics industry.

Chapter 3: Detailed analysis of Tuberculosis (TB) Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis (TB) Diagnosticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Culture-Based Diagnostics Table 3. Key Players of Sputum Smear Microscopy Table 4. Key Players of Rapid Molecular Diagnostics Table 3. Key Players of Others Table 4. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Diagnostic Laboratories Table 6. Key Players of Hospitals Table 7. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Tuberculosis (TB) Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Tuberculosis (TB) Diagnostics Market Share by Region (2021-2026) Table 10. Global Tuberculosis (TB) Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Tuberculosis (TB) Diagnostics Market Share by Region (2027-2032) Table 12. Tuberculosis (TB) Diagnostics Industry Trends Table 13. Tuberculosis (TB) Diagnostics Industry Drivers Table 14. Tuberculosis (TB) Diagnostics Industry Opportunities and Challenges Table 15. Tuberculosis (TB) Diagnostics Industry Restraints Table 16. Global Tuberculosis (TB) Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2021-2026) Table 18. Global Tuberculosis (TB) Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Tuberculosis (TB) Diagnostics Key Company Head Office and Area Served Table 20. Global Tuberculosis (TB) Diagnostics Company, Product Type & Application Table 21. Global Tuberculosis (TB) Diagnostics Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Tuberculosis (TB) Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Tuberculosis (TB) Diagnostics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Tuberculosis (TB) Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Tuberculosis (TB) Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2021-2026) Table 28. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2027-2032) Table 29. Global Tuberculosis (TB) Diagnostics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Tuberculosis (TB) Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Tuberculosis (TB) Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2021-2026) Table 33. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2027-2032) Table 34. Danaher Company Information Table 35. Danaher Business Overview Table 36. Danaher Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Danaher Tuberculosis (TB) Diagnostics Product Portfolio Table 38. Danaher Recent Development Table 39. Roche Company Information Table 40. Roche Business Overview Table 41. Roche Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Roche Tuberculosis (TB) Diagnostics Product Portfolio Table 43. Roche Recent Development Table 44. Thermo Fisher Scientific Company Information Table 45. Thermo Fisher Scientific Business Overview Table 46. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio Table 48. Thermo Fisher Scientific Recent Development Table 49. BD Company Information Table 50. BD Business Overview Table 51. BD Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. BD Tuberculosis (TB) Diagnostics Product Portfolio Table 53. BD Recent Development Table 54. Abbott Company Information Table 55. Abbott Business Overview Table 56. Abbott Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Abbott Tuberculosis (TB) Diagnostics Product Portfolio Table 58. Abbott Recent Development Table 59. Hologic Company Information Table 60. Hologic Business Overview Table 61. Hologic Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Hologic Tuberculosis (TB) Diagnostics Product Portfolio Table 63. Hologic Recent Development Table 64. Qiagen Company Information Table 65. Qiagen Business Overview Table 66. Qiagen Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Qiagen Tuberculosis (TB) Diagnostics Product Portfolio Table 68. Qiagen Recent Development Table 69. BioMerieux Company Information Table 70. BioMerieux Business Overview Table 71. BioMerieux Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio Table 73. BioMerieux Recent Development Table 74. Hain Lifescience Company Information Table 75. Hain Lifescience Business Overview Table 76. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio Table 78. Hain Lifescience Recent Development Table 79. Oxford Immunotec Company Information Table 80. Oxford Immunotec Business Overview Table 81. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio Table 83. Oxford Immunotec Recent Development Table 84. North America Tuberculosis (TB) Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 85. North America Tuberculosis (TB) Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 86. North America Tuberculosis (TB) Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 87. North America Tuberculosis (TB) Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 88. North America Tuberculosis (TB) Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026) Table 90. North America Tuberculosis (TB) Diagnostics Market Size by Country (2027-2032) Table 91. Europe Tuberculosis (TB) Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 92. Europe Tuberculosis (TB) Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 93. Europe Tuberculosis (TB) Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 94. Europe Tuberculosis (TB) Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 95. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026) Table 97. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2027-2032) Table 98. China Tuberculosis (TB) Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 99. China Tuberculosis (TB) Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 100. China Tuberculosis (TB) Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 101. China Tuberculosis (TB) Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 102. Asia Tuberculosis (TB) Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 103. Asia Tuberculosis (TB) Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 104. Asia Tuberculosis (TB) Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 105. Asia Tuberculosis (TB) Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 106. Asia Tuberculosis (TB) Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Asia Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026) Table 108. Asia Tuberculosis (TB) Diagnostics Market Size by Country (2027-2032) Table 109. South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 110. South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 111. South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026) Table 115. South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2027-2032) Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Tuberculosis (TB) Diagnostics Product Image Figure 2. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Tuberculosis (TB) Diagnostics Market Share by Type: 2025 VS 2032 Figure 4. Culture-Based Diagnostics Image Figure 5. Sputum Smear Microscopy Image Figure 6. Rapid Molecular Diagnostics Image Figure 7. Others Image Figure 8. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Tuberculosis (TB) Diagnostics Market Share by Application: 2025 VS 2032 Figure 10. Diagnostic Laboratories Image Figure 11. Hospitals Image Figure 12. Global Tuberculosis (TB) Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 14. Global Tuberculosis (TB) Diagnostics Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Tuberculosis (TB) Diagnostics Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Tuberculosis (TB) Diagnostics Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Tuberculosis (TB) Diagnostics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2021-2032) Figure 21. Global Tuberculosis (TB) Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2021-2032) Figure 23. North America Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 24. North America Tuberculosis (TB) Diagnostics Market Share by Type (2021-2032) Figure 25. North America Tuberculosis (TB) Diagnostics Market Share by Application (2021-2032) Figure 26. North America Tuberculosis (TB) Diagnostics Market Share by Country (2021-2032) Figure 27. United States Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 28. Canada Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 30. Europe Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 31. Europe Tuberculosis (TB) Diagnostics Market Share by Type (2021-2032) Figure 32. Europe Tuberculosis (TB) Diagnostics Market Share by Application (2021-2032) Figure 33. Europe Tuberculosis (TB) Diagnostics Market Share by Country (2021-2032) Figure 34. Germany Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 35. France Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 37. Italy Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 38. Russia Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 40. China Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 41. China Tuberculosis (TB) Diagnostics Market Share by Type (2021-2032) Figure 42. China Tuberculosis (TB) Diagnostics Market Share by Application (2021-2032) Figure 43. Asia Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 44. Asia Tuberculosis (TB) Diagnostics Market Share by Type (2021-2032) Figure 45. Asia Tuberculosis (TB) Diagnostics Market Share by Application (2021-2032) Figure 46. Asia Tuberculosis (TB) Diagnostics Market Share by Country (2021-2032) Figure 47. Japan Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 51. India Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 52. Australia Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Share by Country (2021-2032) Figure 57. Brazil Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 62. UAE Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 64. Chile Tuberculosis (TB) Diagnostics Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Culture-Based Diagnostics
  • Sputum Smear Microscopy
  • Rapid Molecular Diagnostics
  • Others
Applications
  • Diagnostic Laboratories
  • Hospitals
Companies covered
  • Danaher
  • Roche
  • Thermo Fisher Scientific
  • BD
  • Abbott
  • Hologic
  • Qiagen
  • BioMerieux
  • Hain Lifescience
  • Oxford Immunotec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Culture-Based Diagnostics
  5. 1.2.3 Sputum Smear Microscopy
  6. 1.2.4 Rapid Molecular Diagnostics
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Diagnostic Laboratories
  11. 1.3.3 Hospitals
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Tuberculosis (TB) Diagnostics Growth Trends by Region
  14. 1.5.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Tuberculosis (TB) Diagnostics Market Size by Region (2021-2026)
  16. 1.5.3 Tuberculosis (TB) Diagnostics Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Tuberculosis (TB) Diagnostics Market Dynamics
  1. 2.1 Tuberculosis (TB) Diagnostics Industry Trends
  2. 2.2 Tuberculosis (TB) Diagnostics Industry Drivers
  3. 2.3 Tuberculosis (TB) Diagnostics Industry Opportunities and Challenges
  4. 2.4 Tuberculosis (TB) Diagnostics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Tuberculosis (TB) Diagnostics Revenue by Company (2021-2026)
  2. 3.2 Global Tuberculosis (TB) Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Tuberculosis (TB) Diagnostics Key Company Head office and Area Served
  4. 3.4 Global Tuberculosis (TB) Diagnostics Company, Product Type & Application
  5. 3.5 Global Tuberculosis (TB) Diagnostics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Tuberculosis (TB) Diagnostics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Tuberculosis (TB) Diagnostics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Tuberculosis (TB) Diagnostics Tier 1, Tier 2, and Tier 3
4 Tuberculosis (TB) Diagnostics Market by Type
  1. 4.1 Global Tuberculosis (TB) Diagnostics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Tuberculosis (TB) Diagnostics Market Size by Type (2021-2032)
  3. 4.3 Global Tuberculosis (TB) Diagnostics Market Size Share by Type (2021-2032)
5 Tuberculosis (TB) Diagnostics Market by Application
  1. 5.1 Global Tuberculosis (TB) Diagnostics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Tuberculosis (TB) Diagnostics Market Size by Application (2021-2032)
  3. 5.3 Global Tuberculosis (TB) Diagnostics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Danaher
  2. 6.1.1 Danaher Company Information
  3. 6.1.2 Danaher Business Overview
  4. 6.1.3 Danaher Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
  6. 6.1.5 Danaher Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Roche Tuberculosis (TB) Diagnostics Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Thermo Fisher Scientific
  14. 6.3.1 Thermo Fisher Scientific Company Information
  15. 6.3.2 Thermo Fisher Scientific Business Overview
  16. 6.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
  18. 6.3.5 Thermo Fisher Scientific Recent Developments
  19. 6.4 BD
  20. 6.4.1 BD Company Information
  21. 6.4.2 BD Business Overview
  22. 6.4.3 BD Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 BD Tuberculosis (TB) Diagnostics Product Portfolio
  24. 6.4.5 BD Recent Developments
  25. 6.5 Abbott
  26. 6.5.1 Abbott Company Information
  27. 6.5.2 Abbott Business Overview
  28. 6.5.3 Abbott Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
  30. 6.5.5 Abbott Recent Developments
  31. 6.6 Hologic
  32. 6.6.1 Hologic Company Information
  33. 6.6.2 Hologic Business Overview
  34. 6.6.3 Hologic Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
  36. 6.6.5 Hologic Recent Developments
  37. 6.7 Qiagen
  38. 6.7.1 Qiagen Company Information
  39. 6.7.2 Qiagen Business Overview
  40. 6.7.3 Qiagen Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
  42. 6.7.5 Qiagen Recent Developments
  43. 6.8 BioMerieux
  44. 6.8.1 BioMerieux Company Information
  45. 6.8.2 BioMerieux Business Overview
  46. 6.8.3 BioMerieux Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
  48. 6.8.5 BioMerieux Recent Developments
  49. 6.9 Hain Lifescience
  50. 6.9.1 Hain Lifescience Company Information
  51. 6.9.2 Hain Lifescience Business Overview
  52. 6.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
  54. 6.9.5 Hain Lifescience Recent Developments
  55. 6.10 Oxford Immunotec
  56. 6.10.1 Oxford Immunotec Company Information
  57. 6.10.2 Oxford Immunotec Business Overview
  58. 6.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
  60. 6.10.5 Oxford Immunotec Recent Developments
7 North America
  1. 7.1 North America Tuberculosis (TB) Diagnostics Market Size (2021-2032)
  2. 7.2 North America Tuberculosis (TB) Diagnostics Market Size by Type
  3. 7.2.1 North America Tuberculosis (TB) Diagnostics Market Size by Type (2021-2026)
  4. 7.2.2 North America Tuberculosis (TB) Diagnostics Market Size by Type (2027-2032)
  5. 7.2.3 North America Tuberculosis (TB) Diagnostics Market Share by Type (2021-2032)
  6. 7.3 North America Tuberculosis (TB) Diagnostics Market Size by Application
  7. 7.3.1 North America Tuberculosis (TB) Diagnostics Market Size by Application (2021-2026)
  8. 7.3.2 North America Tuberculosis (TB) Diagnostics Market Size by Application (2027-2032)
  9. 7.3.3 North America Tuberculosis (TB) Diagnostics Market Share by Application (2021-2032)
  10. 7.4 North America Tuberculosis (TB) Diagnostics Market Size by Country
  11. 7.4.1 North America Tuberculosis (TB) Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
  13. 7.4.3 North America Tuberculosis (TB) Diagnostics Market Size by Country (2027-2032)
  14. 7.4.4 North America Tuberculosis (TB) Diagnostics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Tuberculosis (TB) Diagnostics Market Size (2021-2032)
  2. 8.2 Europe Tuberculosis (TB) Diagnostics Market Size by Type
  3. 8.2.1 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Tuberculosis (TB) Diagnostics Market Share by Type (2021-2032)
  6. 8.3 Europe Tuberculosis (TB) Diagnostics Market Size by Application
  7. 8.3.1 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Tuberculosis (TB) Diagnostics Market Share by Application (2021-2032)
  10. 8.4 Europe Tuberculosis (TB) Diagnostics Market Size by Country
  11. 8.4.1 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Tuberculosis (TB) Diagnostics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Tuberculosis (TB) Diagnostics Market Size (2021-2032)
  2. 9.2 China Tuberculosis (TB) Diagnostics Market Size by Type
  3. 9.2.1 China Tuberculosis (TB) Diagnostics Market Size by Type (2021-2026)
  4. 9.2.2 China Tuberculosis (TB) Diagnostics Market Size by Type (2027-2032)
  5. 9.2.3 China Tuberculosis (TB) Diagnostics Market Share by Type (2021-2032)
  6. 9.3 China Tuberculosis (TB) Diagnostics Market Size by Application
  7. 9.3.1 China Tuberculosis (TB) Diagnostics Market Size by Application (2021-2026)
  8. 9.3.2 China Tuberculosis (TB) Diagnostics Market Size by Application (2027-2032)
  9. 9.3.3 China Tuberculosis (TB) Diagnostics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Tuberculosis (TB) Diagnostics Market Size (2021-2032)
  2. 10.2 Asia Tuberculosis (TB) Diagnostics Market Size by Type
  3. 10.2.1 Asia Tuberculosis (TB) Diagnostics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Tuberculosis (TB) Diagnostics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Tuberculosis (TB) Diagnostics Market Share by Type (2021-2032)
  6. 10.3 Asia Tuberculosis (TB) Diagnostics Market Size by Application
  7. 10.3.1 Asia Tuberculosis (TB) Diagnostics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Tuberculosis (TB) Diagnostics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Tuberculosis (TB) Diagnostics Market Share by Application (2021-2032)
  10. 10.4 Asia Tuberculosis (TB) Diagnostics Market Size by Country
  11. 10.4.1 Asia Tuberculosis (TB) Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Tuberculosis (TB) Diagnostics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Tuberculosis (TB) Diagnostics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Tuberculosis (TB) Diagnostics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst